ANIP · Ani Pharmaceuticals Inc · Documents
$72.61
-1.14 (-1.55%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.67B
Shares
22.97M
Volume · Oct 23
318.61K
Avg daily vol (3M)
382.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2024-11-08 | 2024-09-30 | |
| 8-K | — | 2024-09-20 | 2024-09-16 | |
| 8-K | — | 2024-09-16 | — | |
| 8-K | — | 2024-08-13 | 2024-08-07 | |
| 8-K | — | 2024-08-08 | 2024-08-07 | |
| 8-K | — | 2024-08-07 | — | |
| 8-K | — | 2024-08-06 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 8-K | — | 2024-06-24 | 2024-06-21 | |
| 8-K | — | 2024-06-05 | — | |
| 8-K | — | 2024-05-23 | 2024-05-21 | |
| 8-K | — | 2024-05-14 | — | |
| 8-K | — | 2024-05-10 | — | |
| 10-Q | — | 2024-05-10 | 2024-03-31 | |
| 8-K | — | 2024-04-17 | — | |
| ARS | — | 2024-04-05 | 2023-12-31 | |
| DEFA14A | — | 2024-04-05 | — | |
| DEF 14A | — | 2024-04-05 | 2023-12-31 | |
| 8-K | — | 2024-03-12 | — | |
| 10-K | — | 2024-02-29 | 2023-12-31 | |
| 8-K | — | 2024-02-29 | — | |
| 8-K | — | 2024-02-23 | 2024-02-16 | |
| 8-K | — | 2024-02-08 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-11-15 | — | |
| 8-K | — | 2023-11-08 | — | |
| 10-Q | — | 2023-11-08 | 2023-09-30 | |
| 8-K | — | 2023-10-02 | — | |
| 8-K | — | 2023-09-25 | — | |
| 8-K | — | 2023-09-12 | 2023-09-11 | |
| 8-K | — | 2023-09-07 | — | |
| 8-K | — | 2023-08-30 | — | |
| 8-K | — | 2023-08-23 | 2023-08-21 | |
| 8-K | — | 2023-08-09 | — | |
| 10-Q | — | 2023-08-09 | 2023-06-30 | |
| 8-K | — | 2023-06-09 | — | |
| 8-K | — | 2023-05-25 | 2023-05-23 | |
| 8-K | — | 2023-05-16 | — | |
| 8-K | — | 2023-05-12 | 2023-05-11 | |
| 8-K | — | 2023-05-11 | — | |
| 8-K | — | 2023-05-08 | 2023-05-07 | |
| 10-Q | — | 2023-05-08 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | — | |
| DEFA14A | — | 2023-05-08 | — | |
| DEF 14A | — | 2023-04-11 | — | |
| ARS | — | 2023-04-11 | 2022-12-31 | |
| DEFA14A | — | 2023-04-11 | — | |
| 8-K | — | 2023-03-10 | — | |
| 10-K | — | 2023-03-09 | 2022-12-31 | |
| 8-K | — | 2023-03-09 | — |
Showing 51–100 of 164 filings
Key facts
CIK
1023024
CUSIP
00182C103
13F (30d)
39 filings
39 filers
Visit website
Investor relations